Leadership

Joint Operations Committe

Kenneth Holroyd, M.D., MBA

Kenneth Holroyd, M.D., MBA

Ken is Vice President for Technology Transfer at Vanderbilt University Medical Center, Medical Director for the Vanderbilt University Center for Technology Transfer and Commercialization, and Associate Professor of Anesthesiology and Medicine. + Read More


Michael Villalobos, Ph.D

Michael Villalobos, Ph.D

Mike joined Vanderbilt University in September 2011 to head up the Biotech Licensing Team and is responsible for commercializing therapeutic, medical device and diagnostic technologies through corporate partnerships. Prior to joining Vanderbilt, he managed the commercialization of technologies for The Cleveland Clinic and Purdue University. + Read More


Gary Sulikowski, Ph.D.

Gary Sulikowski, Ph.D.

Gary is the Stevenson Professor of Chemistry at the Vanderbilt University Department of Chemistry, the Director of the Vanderbilt Institute of Chemical Biology, and the co-PI of the Vanderbilt Center for Cancer Drug Discovery (VCCDD). + Read More


Howie Furst, M.D.

Howie Furst, M.D.

Howie is a Partner on the Biotech team at Deerfield and a physician with 11 years of clinical experience. Howie joined Deerfield in 2007 and provides extensive research and analysis on individual companies operating in the healthcare industry. + Read More


William Slattery

William Slattery

Bill is a Partner on the Private Transactions team at Deerfield, which he joined in 2000. He began his professional career studying immune system complications associated with End Stage Renal Disease. Prior to joining Deerfield, Bill was a senior healthcare analyst between 1990 and 2000 at Amerindo Investment Advisors overseeing biotechnology investments. + Read More


Joe Pearlberg, M.D., Ph.D

Joe Pearlberg, M.D., Ph.D

Joe Pearlberg, M.D., Ph.D., is the Vice President of Scientific Affairs at Deerfield, which he joined in July 2017. Prior to joining Deerfield he was the Vice President of Clinical Development at Infinity Pharmaceuticals from December 2015 until July 2017. + Read More


Alliance Manager

Margaret Read

Margaret Read

Margaret is the Alliance Manager for Ancora Innovation. Prior to joining Ancora Innovation, she was an independent consultant in the oncology sector for biotechnology and pharmaceutical companies. + Read More


HOW CAN WE HELP?

Contact us if you have any questions or would like to request a proposal.